Blood transfusion

Blood Group Typing Market is Projected to Reach US$ 3,556.0 Mn by 2026, Says TMR

Retrieved on: 
Wednesday, August 22, 2018
Hematology, Transfusion medicine, Medicine, Biology, Health care, Blood transfusion, Blood type, Typing, Blood

According to the report, the global blood group typing market was valued at US$ 1,500.0 Mn in 2017 and is projected to reach US$ 3,556.0 Mn by 2026, expanding at a high CAGR of 10.3% from 2018 to 2026.

Key Points: 
  • According to the report, the global blood group typing market was valued at US$ 1,500.0 Mn in 2017 and is projected to reach US$ 3,556.0 Mn by 2026, expanding at a high CAGR of 10.3% from 2018 to 2026.
  • Increase in blood transfusion rate across the world is anticipated to fuel the global blood group typing market during the forecast period.
  • The blood group typing market in Latin America is likely to expand at a moderate growth rate during the forecast period.
  • Request a Sample of Blood Group Typing Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    The report offers detailed segmentation of the global blood group typing market based on product, technique, test, and end-user.

Rexel Energy Solutions giving back to the community with Red Cross blood drive

Retrieved on: 
Tuesday, August 14, 2018
Rexel, Energy conservation, Energy service company, Taunton, Blood transfusion, Economy

TAUNTON, Mass., Aug. 14, 2018 /PRNewswire/ --Rexel Energy Solutions will host a community blood drive with the American Red Cross on Thursday, September 6, 2018 from 10 AM to 3 PM at the Holiday Inn Taunton in Governor's III Ballroom located at 700 Myles Standish Blvd.

Key Points: 
  • TAUNTON, Mass., Aug. 14, 2018 /PRNewswire/ --Rexel Energy Solutions will host a community blood drive with the American Red Cross on Thursday, September 6, 2018 from 10 AM to 3 PM at the Holiday Inn Taunton in Governor's III Ballroom located at 700 Myles Standish Blvd.
  • "Hosting a blood drive coincides with Rexel Energy Solutions' core values of giving back to the community," said Christopher Monoson, President and General Manager.
  • Blood is routinely transfused to patients with cancer and other diseases, premature babies, organ transplant recipients and trauma victims, according to the Red Cross.
  • Rexel Energy Solutions, a stand-alone business within Rexel USA, is a specialized national team of lighting and controls experts to support ESCOs across the country.Since 1942, the Rexel Energy Solutions team, formerly Munro Distributing Company, Inc., has provided energy conservation solutions and support to contractors, ESCOs, and Utility partners nationwide.With a team built to support Energy Efficiency Providers from specification and quotation through post-construction support, Rexel Energy Solutions is focused on improving their customer's cash flow and reducing their construction expense.

Domino's® Joins the American Red Cross' Missing Types Campaign

Retrieved on: 
Thursday, June 14, 2018
Transfusion medicine, Hematology, Domino's Pizza, Blood, Blood donation, DPZ, Blood transfusion, American Red Cross, Fast food, Health, Pizza

ANN ARBOR, Mich., June 14, 2018 /PRNewswire/ -- Domino's (NYSE: DPZ), the largest pizza company in the world based on global retail sales, is supporting the American Red Cross and its latest Missing Types campaign to recruit blood donors.

Key Points: 
  • ANN ARBOR, Mich., June 14, 2018 /PRNewswire/ -- Domino's (NYSE: DPZ), the largest pizza company in the world based on global retail sales, is supporting the American Red Cross and its latest Missing Types campaign to recruit blood donors.
  • "Everyday thousands of patients across the United States rely on generous blood donors for critical blood transfusions," said Gail McGovern, president and CEO of the Red Cross.
  • We urge the public to roll up a sleeve and fill the missing types before these lifesaving letters go missing from hospital shelves."
  • "We hope that delivering the facts to fans of Domino's will bring new donors to the Red Cross."

Disappearing A's, B's and O's: Red Cross launches #MissingType campaign to urge new blood donors to give

Retrieved on: 
Monday, June 11, 2018
Blood, Transfusion medicine, Hematology, Medicine, Anatomy, Blood donation, Blood transfusion, Blood type

"Everyday thousands of patients across the United States rely on generous blood donors for critical blood transfusions," said Gail McGovern, president and CEO of the Red Cross.

Key Points: 
  • "Everyday thousands of patients across the United States rely on generous blood donors for critical blood transfusions," said Gail McGovern, president and CEO of the Red Cross.
  • In fact, for the past four years, new Red Cross donors have declined by about 80,000 each year.
  • Join the #MissingType movementmake an appointment to give blood by visiting redcrossblood.org, using the Red Cross Blood Donor App or calling 1-800-REDCROSS (1-800-733-2767).
  • * Good news Potential blood donors do not need to know their blood type before giving blood.

ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics

Retrieved on: 
Friday, June 1, 2018
Medicine, Transfusion medicine, Anatomy, Hematology, Health, Medical tests, Ortho Clinical Diagnostics, Ortho, Blood, Blood transfusion, Immunohaematology, International Society of Blood Transfusion

RARITAN, N.J., June 1, 2018 /PRNewswire/ --Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that it will host a satellite symposium, co-sponsored with Quotient Limited (QTNT), titled "Responding to the Challenges of Resource Constraints in Transfusion Diagnostics", during the 35th International Congress of the International Society of Blood Transfusion (ISBT).

Key Points: 
  • RARITAN, N.J., June 1, 2018 /PRNewswire/ --Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that it will host a satellite symposium, co-sponsored with Quotient Limited (QTNT), titled "Responding to the Challenges of Resource Constraints in Transfusion Diagnostics", during the 35th International Congress of the International Society of Blood Transfusion (ISBT).
  • "The speakers at our symposium will identify the critical challenges facing transfusion medicine now and in the future," said Heidi Casaletto, vice president of Transfusion Medicine at Ortho.
  • Ortho will also share the following poster presentations at ISBT:
    Presenters: Tony S. Casina of Ortho Clinical Diagnostics, Raritan and Wim Malomgre of Ortho Clinical Diagnostics, Turnhout, Belgium
    Presenters: Tony S. Casina of Ortho Clinical Diagnostics, Raritan and Wim Malomgre of Ortho Clinical Diagnostics, Turnhout, Belgium
    Additionally, at ISBT, Ortho will feature the award-winning ORTHO VISION platform, which has received a string of accolades for its ability to innovate in transfusion medicine.
  • Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities.

FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure

Retrieved on: 
Monday, May 21, 2018
Blood, Anatomy, Medicine, Transfusion medicine, Hematology, Coagulation system, Blood products, Platelet, Coagulation, Thrombocytopenia, Blood transfusion, Thrombus

This drug may decrease or eliminate the need for platelet transfusions, which are associated with risk of infection and other adverse reactions."

Key Points: 
  • This drug may decrease or eliminate the need for platelet transfusions, which are associated with risk of infection and other adverse reactions."
  • Platelets (thrombocytes) are colorless cells produced in the bone marrow that help form blood clots in the vascular system and prevent bleeding.
  • Thrombocytopenia is a condition in which there is a lower-than-normal number of circulating platelets in the blood.
  • People with chronic liver disease and people with certain blood clotting conditions may have an increased risk of developing blood clots when taking Doptelet.

Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

Retrieved on: 
Monday, May 14, 2018
Transfusion medicine, Hematology, Medicine, Health care, Health, Grifols, Blood transfusion, Immunohaematology, Cross-matching, Antiserum, Blood type, Transfusion

The U.S. Food & Drug Administration recently granted licensing approval for Grifols to commercialize a range of antisera reagents designed for routine and complex immunohematology testing.

Key Points: 
  • The U.S. Food & Drug Administration recently granted licensing approval for Grifols to commercialize a range of antisera reagents designed for routine and complex immunohematology testing.
  • "Accelerating growth in the U.S. transfusion medicine market is a strategic objective for Grifols.
  • The addition of these reagents to our blood typing solutions portfolio significantly broadens our product offering and delivers increased value to our customers," said Carsten Schroeder, President, Grifols Diagnostic Division.
  • Manual techniques for blood typing and pretransfusion testing continue to be a large segment in the U.S. blood transfusion industry.

Quotient Limited Announces FDA Approval of Seven Blood Bank Reagents, Including Two Market Firsts

Retrieved on: 
Tuesday, April 24, 2018
Anatomy, Transfusion medicine, Blood, Medicine, Hematology, Blood transfusion, Antiserum

The introduction of these new products is a continuation of Quotient's promise to innovate and grow our product offering in the US market," Mr Brady added.

Key Points: 
  • The introduction of these new products is a continuation of Quotient's promise to innovate and grow our product offering in the US market," Mr Brady added.
  • Anti-Human Globulin (AHG) is an essential tool for laboratories responsible for blood transfusion.
  • ALBAclone monoclonal antisera are used in the laboratory to detect the presence of specific antigens on patient and donor red blood cells.
  • The Quotient logo and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.